Scanning through billions of chemicals to find a few potential drugs for treating COVID-19 requires computers that harness together thousands of processors.
Rigor académico, oficio periodístico
Artículos sobre SARS-CoV-2
Mostrando 441 - 460 de 583 artículos
The use of antihypertension medication during the coronavirus pandemic has been a subject of hot debate but people should be cautious about simple conclusions.
A continuous lock down is detrimental to Nigeria’s large population of people living below poverty lines, but lifting the restrictions without a proper plan is equally dangerous. Here’s what to do.
Antibodies that recognize and block SARS-CoV-2 infection have the potential to be powerful weapons. An infectious disease expert explains what antibodies are and how they could be used as a therapy.
Getting the control measures right is critical.
An antigen test was given emergency use authorization by the FDA in early May. A biochemist explains how COVID-19 antigen tests work.
Since the state’s first coronavirus case surfaced, trained case investigators have traced the contacts of every person who tested positive. Here’s what else South Carolina got right.
Here’s what we know about immunity to COVID-19, and what that means for getting life back to normal.
Countries across the globe responded differently to the pandemic, and results show a difference in effectiveness as well.
A potential vaccine for coronavirus is undergoing a human trial in Australia. It’s based on a vaccine that was already in development for influenza, and has shown promise in animal studies.
Immunity to COVID-19 may be complicated. Here are the promises and pitfalls of antibody tests.
Thinking of SARS-CoV-2 as an invisible enemy with an evil personality and humanlike motivations is a natural offshoot of the way people evolved to anthropomorphize so as not to overlook threats.
Drama on massive production and importation of HCQ/CQ throughout the world has once again served as a reminder that public policy must stand on solid scientific foundation.
You’re heading to your first post-COVID-19 dinner party. How many guests is too many? Are hugging and handshakes OK now? And most importantly, should you bring your own cutlery?
One of the methods researchers are exploring to combat COVID-19 is gene editing: altering the genome of the virus to make it harmless.
It’s human nature to try to insulate yourself from the unpleasant realization that death comes for all of us eventually.
Results from phase 1 trials of a COVID-19 mRNA vaccine created a burst of optimism. But details the company failed to release suggest it is too early to speculate whether the vaccine is effective.
The US president has reignited controversy over the use of malaria drugs to guard against COVID-19. But there is little reliable evidence so far that this tactic is safe or effective.
Bats get a lot of negative press, but they also make positive contributions to the environment and to our lives.
We blame the coronavirus for the thousands of deaths, but it is actually a hyperactive immune reaction that is the cause of death. An immunologist explains.
Principales colaboradores
-
Professor of Medicine, University of Virginia
-
Research associate, Warren Alpert Medical School, Brown University, Brown University
-
Associate Professor, Epidemiology, Deakin University
-
Dean Faculty of Health Sciences and Professor of Vaccinology at University of the Witwatersrand; and Director of the SAMRC Vaccines and Infectious Diseases Analytics Research Unit, University of the Witwatersrand
-
Vice-Chancellor's Research Fellow, School of Health and Biomedical Sciences, RMIT University
-
Professor of Global Biosecurity, NHMRC L3 Research Fellow, Head, Biosecurity Program, Kirby Institute, UNSW Sydney
-
Instructor of Human Immunology, Emory University
-
Postdoctoral Fellow in Virology, University of Colorado Boulder
-
Postdoctoral Fellow in Virology and Immunology, University of Colorado Boulder
-
Professor, Nursing, School of Nursing and Midwifery, Griffith University
-
Research Leader in Virology and Infectious Disease, Griffith University
-
Research Fellow in Virology, University of Leeds
-
Lecturer in Virology, Queen's University Belfast
-
Professor of Molecular, Cellular and Developmental Biology, University of Colorado Boulder
-
Professor of Pathology, Microbiology and Immunology, University of South Carolina
